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Edited by Jesus AvilaAbstract The thioredoxin system, composed of thioredoxin
(Trx) and thioredoxin reductase (TrxR), emerges as one of the
most important thiol-based systems involved in the maintenance
of the cellular redox balance. Thioredoxin-like-1 (TXL-1) is a
highly conserved protein comprising an N-terminal Trx domain
and a C-terminal domain of unknown function. Here we show
that TXL-1 is a substrate for the cytosolic selenoprotein
TrxR-1. In situ hybridization experiments demonstrates high
expression of Txl-1 mRNA in various areas of central nervous
system and also in some reproductive organs. Glucose depriva-
tion, but not hydrogen peroxide treatment, reduced the levels
of endogenous TXL-1 protein in HEK-293 cell line. Conversely,
overexpression of TXL-1 protects against glucose deprivation-in-
duced cytotoxicity. Taken together, the ﬁnding that Txl-1
mRNA is highly expressed in tissues which use glucose as a pri-
mary energy source and the modulation of TXL-1 levels upon
glucose deprivation indicate that TXL-1 might be involved in
the cellular response to sugar starvation stress.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Thioredoxin; Glucose deprivation; Cell death; Stress1. Introduction
The thioredoxin (Trx) family encompasses a group of redox
proteins that function as general protein disulﬁde reductases
[8] participating in many physiological and pathophysiological
processes [1,5]. The redox activity of Trx is directly linked to
their highly conserved active site (Cys-Gly-Pro-Cys) where
the cysteine residues can undergo a reversible oxidation from
a dithiol to a disulﬁde form. Oxidized inactive forms are re-
duced by the selenoprotein thioredoxin reductase (TrxR),
which uses the reducing power of NADPH [9]. Trxs share a
common globular structure consisting of a central core of b-
sheets surrounded by a-helixes with the active site situated in
a protrusion of the protein surface [12].Abbreviations: DTT, dithiothretitol; GST, glutathione-S-transferase;
MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide;
Trx, thioredoxin; TrxR, thioredoxin reductase; Txl, thioredoxin-like;
HEK, human embryonic kidney
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doi:10.1016/j.febslet.2006.01.025Diﬀerent forms of Trxs have been reported in all organisms
from prokaryotes to humans. In eukaryotic organisms Trxs
are located in diﬀerent subcellular compartments and are
found either ubiquitously expressed or speciﬁcally localized
in particular tissues [2,8,11,17,20,21,23]. Some of the previ-
ously described Trxs comprise additional domains with known
or unknown counterparts in the databases [2,17,21,22,26,27].
Thioredoxin-like 1 (TXL-1), also known as TRP32 [17,21] is
a two-domain protein of 32 kDa composed of a N-terminal Trx
domain followed by a C-terminal domain of unknown function
with no homology with any other protein in the databases.
TXL-1 mRNA is ubiquitously localized in all human tissues
examined so far, although it is present at highest levels in tissues
with an elevated metabolic rate [17,21]. The crystal structure of
the TXL-1 N-terminal domain has been solved [14] and shows a
monomeric structure, in contrast to the ubiquitous cytosolic
TRX-1 which is dimeric in all crystal structures reported [37].
We report here novel features of human TXL-1 concerning
its ability to serve as substrate for TrxR-1, new insights into
its tissue localization and, more importantly, that TXL-1 is in-
volved in the cellular response to glucose deprivation.2. Materials and methods
2.1. Materials
All media and supplements used for cell culture including glucose-
free DMEM were purchased from Life Technologies. Bovine TrxR-1
was from IMCO (Sweden). pET-15b vector was obtained from Nova-
gen and pGEX-4T-1 vector was from Amersham Biosciences.
pCDNA-myc empty vector was a gift from Dr. Eckardt Treuter.
Anti-myc monoclonal antibody was purchased from Invitrogen.
H2O2, Trypan Blue and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltet-
razolium bromide (MTT) reagents were obtained from Sigma–Aldrich.
2.2. Human TXL-1 protein expression and puriﬁcation
The ORF encoding human TXL-1 was cloned into the BamHI–
EcoRI sites of the pGEX-4T-1 expression vector and used to transform
Escherichia coli HMS174(DE3). Induction and puriﬁcation of the re-
combinant protein was achieved as previously reported [21]. Thrombin
(5 U/mg of fusion protein) was used to remove the glutathione-S-trans-
ferase (GST) domain by incubation overnight at 4 C. The resulting
protein preparation was then subjected to ion exchange chromatogra-
phy using a Resource Q column (Amersham Biosciences), and human
TXL-1 was eluted as a single peak using a gradient of NaCl. Protein
concentration was determined with the Bio-Rad protein assay kit
(Bio-Rad) using BSA as a standard.blished by Elsevier B.V. All rights reserved.
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Fig. 1. Reducing activity of human TXL-1. TRX-1 (d) and puriﬁed
TXL-1 (m, 10 lg; h, 20 lg) were assayed for their ability to reduce
insulin disulﬁde bonds in the presence of NADPH and calf thymus
TrxR-1. Reactions with TrxR-1 alone (s) served as controls. A total of
1 lg of TrxR-1 was used in each reaction. Identical results were
obtained from three independent experiments.
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Enzymatic activity of recombinant human TXL-1 was performed
using two diﬀerent assays. In the DTT assay, dithiothretitol (DTT) is
used as reducing agent and the assay was carried out as previously de-
scribed [38]. In the TrxR assay, recombinant TXL-1 activity was deter-
mined by its capability to reduce insulin disulﬁde bonds using NADPH
as electron donor in the presence of calf thymus TrxR-1. The activity
assay was performed essentially as described elsewhere [33] but moni-
toring insulin precipitation at 600 nm. In both cases, human TRX-1
was used as control.
2.4. Antibody production
Puriﬁed His-hTXL-1 [21] was used to immunize rabbits (Zeneca Re-
search Biochemicals). After six immunizations, serum from rabbits was
puriﬁed by ammonium sulfate precipitation. Aﬃnity-puriﬁed antibod-
ies were prepared as described [24] using the TXL-1 fragment from the
GST-TXL-1 recombinant protein. The speciﬁcity of the antibodies was
tested by western blot. Immunodetection was performed with horse-
radish peroxidase-conjugated donkey anti-rabbit IgG diluted 1/5000
following the ECL protocol (Amersham Biosciences). Additionally,
aﬃnity puriﬁed polyclonal rabbit anti-TXL-1 and the respective block-
ing peptide were purchased from Abgent (San Diego, USA) for immu-
nocytochemistry.
2.5. In situ hybridization
Adult (NMRI, weighting 20–25 g) and embryonic (embryonic days
E9–E18; E1 = the day of copulation plug) mice were used. Adult ani-
mals were killed with carbon dioxide, the tissues and embryos were
rapidly excised, and frozen on dry ice. The frozen tissues were sec-
tioned with Microm HM-500 cryostat at 14 lm and mounted on Poly-
lysine glass slides (Menzel, Braunschweig, Germany). The sections
were stored at 20 C until use. Three oligonucleotide probes directed
against mouse and rat Txl-1 mRNA (mouse nucleotides 189–222, 263–
294 and 361–394, GeneBank Accession No. NM_016792) were used
for in situ hybridization. The sequences exhibited less than 60% homol-
ogy with other known genes in the GeneBank database. Several probes
against non-related mRNAs with known expression patterns and with
similar length and GC-content were used as controls. Addition of 100-
fold excess of non-labeled probes quenched all signal. The in situ
hybridization was carried out as described in detail previously [28].
2.6. Immunocytochemistry
For immunocytochemistry adult NMRImice were perfused ﬁrst with
20 ml of physiological saline followed with 50 ml of 4% paraformalde-
hyde in phosphate buﬀered saline (PBS, 0.1 M, pH 7.3). The brains
were excised and further immersed in the same ﬁxative for 1 h. After
cryoprotection with 20% sucrose the tissues were sectioned at 10 lm
inMicrom 500 HM cryostat. Sections were incubated with the antibody
(dil. 1:100) overnight in PBS containing 1% BSA and 0.1% Triton X-
100. Immunoreactivity was visualized with Vectastain Elite-kit (Vector
Laboratories, Burlingame, CA, USA) using nickel-intensiﬁed diam-
inobenzidine as a chromogen. Presaturation of the antibody with
40 lg of the blocking peptide and omission of the primary or secondary
antibodies abolished all staining. Sections were examined under a Ni-
kon FXA microscope equipped with a PCO Sensicam digital camera
(PCO, Kelheim, Germany) and the images were processed using Corel
Draw software (Corel Corporation Ltd., Ont., Canada).
2.7. Cell culture and transient transfections
Human embryonic kidney (HEK)-293 cells were cultured at 37 C in
an atmosphere of 5% CO2 in DMEM medium supplemented with 10%
fetal bovine serum, 100 U/ml penicillin and 100 lg/ml streptomycin.
Transfection experiments were carried out as described elsewhere [13].
2.8. Stable transfection of HEK-293 cells
Plasmids pCDNA-myc and pCDNAmyc/TXL-1 were transfected
into HEK-293 cells. Selection for G418 resistance (1 mg/ml) was initi-
ated 48 h after transfection and individual clones were isolated to ob-
tain three diﬀerent stable cell lines: control clone transfected with
empty pCDNAmyc vector and two clones transfected with pCDNA-
myc/TXL-1 showing diﬀerent TXL-1 expression levels. TXL-1 overex-
pression was conﬁrmed by western-blot analysis using anti-myc (not
shown) and anti-TXL-1 antibodies.2.9. MTT cell viability assay
Cell viability was assessed by MTT assay [25] that detects the cel-
lular ability to transform MTT tetrazolium salt into formazan. MTT
(0.3 mg/ml in DMEM without phenol red) was added to the cells.
After 1 h incubation at 37 C, the medium was removed and the for-
mazan crystals were dissolved in the same volume of isopropanol.
Aliquots were transferred to 96-well plates and the absorbance
was measured at 540 nm. Results were expressed as a percentage
of viable cells.
2.10. Statistical analysis
Analyses of diﬀerences were carried out by ANOVA followed by the
Student–Newman–Keuls post hoc test. A value of P < 0.05 was consid-
ered statistically signiﬁcant.3. Results
3.1. Txl-1 is a two-domain protein conserved from ﬁssion yeast
to humans
A protein–protein BLASTp search was performed to iden-
tify human TXL-1 orthologues in the public databases
(http://www.ncbi.nlm.nih.gov/BLAST/), which resulted in sev-
eral entries from the ﬁssion yeast to mammals. All these se-
quences were run on a W-Clustal alignment using the
MegAlign program included in the DNAstar software package
(Supplemental Data Fig. 1). Txl-1 protein is well conserved
from lower eukaryotes to humans and the high identity is
not only conﬁned to the Trx domain, but being comparable
all along the protein sequence. All the Txl-1 proteins analyzed
are about the same length (290 residues) and contain many of
the amino acid residues identiﬁed as essential for catalysis,
maintenance of three-dimensional structure or protein–protein
interactions in previously characterized Trxs [3].
As mentioned above, Txl-1 is a two-domain protein with an
N-terminal Trx domain and a C-terminal domain with un-
known function [17,21]. Nonetheless, the examination of the
Conserved Domain Database at NCBI (http://www.ncbi.nlm.
nih.gov/Structure/cdd/cdd.shtml) showed that two other clas-
ses of proteins diﬀerent than Txl-1 contain a homologous
domain, which is named Domain of Unknown Function
962 A. Jime´nez et al. / FEBS Letters 580 (2006) 960–9671000 (DUF1000). These two classes of proteins are the eukary-
otic HT014 proteins, which comprise a unique DUF1000
domain, and the Caenorhabditis elegans ZK353.1 protein that
encompasses a Cyclin N-terminal domain (Cyclin box fold)
and a C-terminal DUF1000 domain.
3.2. Human TXL-1 has reducing activity coupled to TrxR
We have now puriﬁed a GST-TXL-1 recombinant protein
and assayed the thrombin-cleaved TXL-1 in the DTT assay
resulting in detectable enzymatic activity, as previously re-Fig. 2. Localization of Txl-1 mRNA in mouse tissues with in situ hybridizat
(hc) and the hypothalamus (hy). Arrowheads show arcuate nucleus of hypo
exhibits moderate signal (A). Strong signal is present in the granular cell l
Neurons (arrowheads) of trigeminal ganglion show moderate expression (C).
while interstitial tissue (it) shows low expression (D). Most of the seminife
epithelium of the tubules (arrowheads) of epididymis shows strong signal (F
Moderate expression is seen throughout the thymus (H). In kidney modera
medulla (im) and renal pelvis are non-labelled (I). Homogenous expression ca
medulla (me) (K). In heart very low signal is in heart muscle (L). In skel
(arrowheads) shows somewhat stronger signal (M). In placenta (pl) strong sig
(triangles) shows low expression. Clear signal is present in the neuroepithelium
F), 230 lm (B), 100 lm (C, E, G), 180 lm (D, H, I, L), 35 lm (J), 65 lm (Kported [17] (data not shown). Recombinant thrombin-cleaved
TXL-1 protein also displayed insulin reducing activity in the
presence of calf thymus TrxR-1 and NADPH (Fig. 1).
Remarkably, the kinetics of TRX-1 and TXL-1 are diﬀerent.
First, TRX-1 shows a 4-fold higher thioredoxin activity than
TXL-1 at the same concentration. Second, TXL-1 activity is
delayed in time when compared to that of TRX-1. TXL-1
starts to show the enzymatic activity after 45 min of initiat-
ing the assay, when TRX-1 has already reached its maximal
activity. This long latency phase explains the failure to detection. High expression of Txl-1 mRNA can be seen in the hippocampus
thalamus and arrows point to habenular nucleus. Cerebral cortex (co)
ayer of cerebellar cortex (co) and some nuclei of brain stem (bs) (B).
In ovary prominent signal is seen in diﬀerent size follicles (arrowheads)
rous tubules (arrowheads) of testis exhibit moderate signal (E). The
). Low signal is present in the epithelium (arrowheads) in prostate (G).
te signal is present in cortex (co) and outer medulla (om) while inner
n be seen liver (J). Low expression is present in adrenal cortex (co) and
etal muscle (mu) of tongue low signal is present and the epithelium
nal is seen in the fetal part (arrowheads) while maternal part and uterus
(arrow) of neural tube of E9 fetus (N). Bar in A represents 210 lm (A,
), 90 lm (M) and 240 lm (N).
Fig. 3. Immunolocalization of Txl-1 in brain tissue. (A) Txl-1
immunoreactivity in cerebellar cortex. Strong nuclear (arrow) and
moderate cytoplasmic staining (arrowheads) can be seen in the
Purkinje cell (pc). Large number of granular neurons (gc) show strong
nuclear and moderate cytoplasmic labeling (arrows) while few exhibit
only moderate cytoplasmic staining (double arrowheads) (mc, molec-
ular layer). (B) Txl-1 immunoreactivity in hypothalamic arcuate
nucleus. Some neurons show clear cytoplasmic staining with low
nuclear labeling (arrowheads) while other neurons exhibit strong
nuclear labeling (arrows). (C) Presaturation control of the adjacent
section to B, no staining can be seen in the control. Bar in A represents
30 lm for A–C.
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[21].
3.3. Txl-1 mRNA tissue distribution
With in situ hybridization in mice, high level of Txl-1
mRNA could be seen in several areas in nervous system.
Especially olfactory bulb, hippocampus, habenular nucleus,
several hypothalamic (Fig. 2A) and brain stem nuclei and
cerebellar cortex (Fig. 2B) showed high expression. In
peripheral nervous system moderate expression was seen in
the neurons of trigeminal and superior cervical ganglion
(Fig. 2C). In reproductive organs high expression was seen
in the granulosa cells of diﬀerent size follicles in ovary, while
interstitial tissue and corpora lutea showed low expression
(Fig. 2D). In testis moderate signal was observed in most
seminiferous tubules (Fig. 2E). In epididymis strong signal
was present in the epithelium of the tubules (Fig. 2F). In
prostate low signal was seen in the epithelium (Fig. 2G)
and in seminal vesicle low expression was seen in the muscle
layer. In immune system moderate levels of Txl-1 mRNA
were observed in thymus (Fig. 2H), spleen and lymph nodes.
In kidney moderate expression was present in the cortex and
outer medulla while inner medulla and pelvis were devoid of
signal (Fig. 2I). In urinary bladder low signal was present in
the epithelium whereas muscle layer was devoid of signal. In
salivary gland and liver (Fig. 2J) moderate homogenous sig-
nal was present. Pituitary gland and adrenal gland (Fig. 2K)
showed low signal while thyroid gland was devoid of signal.
In heart (Fig. 2L) and striated muscle (Fig. 2M) expression
of Txl-1 mRNA was low. In skin low expression could be
detected (Fig. 2M). Strong Txl-1 mRNA expression was seen
in the embryonic side of the E9 placenta, while maternal side
showed low expression. In E9 fetus clear signal was seen in
the neuroepithelium of developing neural tube (Fig. 2N).
Most organs which express Txl-1 mRNA in adults showed
expression already during fetal development (data not
shown).
3.4. Immunocytochemical localization of TXL-1 in brain
As the central nervous system is one of the organs showing
high levels of Txl-1mRNA, we further analyzed the expression
pattern of Txl-1 protein in mouse brain tissue by immunocyto-
chemistry.
Txl-1 immunoreactivity could be seen in several brain
areas. Strong staining was seen in, e.g., cerebral and cerebel-
lar cortex (Fig. 3A) and hypothalamus (Fig. 3B). In cerebel-
lar Purkinje neurons strong nuclear staining was evident.
Moderate to low labeling was seen in the cytoplasm
(Fig. 3A). Large number of granular neurons showed strong
nuclear labeling and weak cytoplasmic staining. Few granu-
lar neurons exhibited moderate cytoplasmic staining with
weak or non-labeled nucleus (Fig. 3A). In hypothalamic
arcuate nucleus both nuclear and cytoplasmic staining was
seen in most of the labeled cells while in some only cytoplas-
mic staining was evident (Fig. 3B). No staining was seen in
the presaturation control (Fig. 3C).
In addition, we clearly observed both nuclear and cyto-
plasmic localization of a TXL-1–GFP fusion protein (Sup-
plemental Data Fig. 2). Although the nuclear staining is
weaker than with a transfection control using the pEGFP-
N3 empty vector expressing the GFP protein alone, a com-
parison with cells transfected with pEGFP-N3/SPTRX-2 thatexpress the cytoplasmic-restricted sperm-speciﬁc SPTRX-2
[26] allow us to unequivocally conﬁrm the nuclear labeling
of TXL-1–GFP fusion protein.
3.5. Glucose deprivation but not hydrogen peroxide aﬀects
TXL-1 expression levels in HEK-293 cells
Brain tissue is very sensitive to ischemia (i.e., hypoxia and
glucose deprivation). In addition, glucose deprivation induces
cell death through a mechanism where metabolic oxidative
stress is involved [18,30,31]. We wanted to know whether
TXL-1 might be involved in this mechanism and therefore we
964 A. Jime´nez et al. / FEBS Letters 580 (2006) 960–967investigated TXL-1 expression in HEK-293 cells after glucose
deprivation. First, we conﬁrmed that glucose deprivation, as re-
ported for other cell lines [18,32], induces cell death in HEK-
293 cells (Fig. 4, left panel). Cytotoxicity is evident after 24 h
of treatment, counting up to 60% of cell death after 48 h. With
regard to TXL-1 expression upon glucose deprivation, TXL-1
protein levels do not change until 32 h (not shown) and decrease
after 36 h when HEK-293 cells are cultured in glucose-free
medium (Fig. 4, right panel). In contrast, glucose deprivation
does not aﬀect TRX-1 or actin protein levels up to 48 h.
Glucose deprivation-induced cytotoxicity is mediated by the
generation of reactive oxygen species such as hydrogen perox-
ide [30]. Based on our previous results, we reasoned that the
downregulation of TXL-1 expression caused by glucose depri-
vation might be mediated by hydrogen peroxide. Therefore, we
checked whether hydrogen peroxide by itself might trigger
modiﬁcations on TXL-1 protein levels. As shown in Fig. 5,
hydrogen peroxide induces HEK-293 cell death within 2 h,
reaching only 50% survival after 6 h, but does not cause any
change in the endogenous levels of TXL-1. Extended incuba-
tion times caused massive cell death without any change in
the levels of TXL-1 (not shown).0
%
 li
vin
g 
ce
lls
20
40
60
80
100
120
0 2 4 6
Time (hours)
Fig. 5. Eﬀect of hydrogen peroxide on HEK-293 cells and TXL-1 protein leve
H2O2 during 6 h. Cell survival was calculated using the Trypan Blue exclusio
treated (0–6 h) with 0.5 mM H2O2 were subjected to western-blot analysis u
0
20
40
60
80
100
120
0 8 24 36 48
Time (hours)
%
 liv
in
g 
ce
lls
Fig. 4. Eﬀect of glucose deprivation on HEK-293 cells and TXL-1 protein le
during 48 h. Cell survival was calculated using the MTT assay and it is represe
in medium with glucose. Right panel, HEK-293 cells were cultured in a glu
lysates (25 lg) from representative time-points were separated by SDS–PAG3.6. TXL-1 overexpression protects against glucose deprivation-
induced cytotoxicity
Next we wanted to know if TXL-1 overexpression might
abolish or delay the cell death induced by glucose deprivation
in HEK-293 cells. For this purpose, we made stable cell lines
overexpressing TXL-1 to check whether constitutively in-
creased TXL-1 protein levels have a protective eﬀect on glu-
cose deprivation-induced cytotoxicity. As shown in Fig. 6,
we managed to isolate two stable clones with diﬀerent TXL-
1 expression levels (TXL-1–6 and TXL-1–16, with high and
low expression levels of recombinant TXL-1, respectively)
and one stable cell line with the pCDNA-myc empty vector
to be used as negative control. Our results indicate that increased
levels of TXL-1 can protect against the cytotoxicity induced by
48–72 h of glucose deprivation (Fig. 6). Thus, TXL-1–6 clone
that expresses high levels of TXL-1 protein shows a signiﬁcant
delay in cell death and a higher rate of survival (about 50%
more living cells than the control) from 48 to 72 h (Fig. 6).
However, TXL-1–16 clone that expresses low levels of TXL-1
is as sensitive as the control. In contrast, TXL-1 overexpression
does not exert any eﬀect against hydrogen peroxide cytotoxicity
(not shown).TXL-1
Actin
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Oxidative stress is involved in the progression of many diﬀer-
ent diseases and it is characterized by the depletion of the gen-
eral antioxidant systems leading to an alteration of the cellular
redox status. Thus, the balance between reactive oxygen spe-
cies production and antioxidants determines the degree of oxi-
dative stress [4]. Trxs have emerged as an essential family of
proteins directly related to the antioxidant cellular network
[5]. Here we present novel features of one member of the thio-
redoxin family, TXL-1.
Txl-1 is one of the best conserved members of the thio-
redoxin family. This fact probably implies an important func-
tion of this protein in the physiology of eukaryotic organisms.
It is also remarkable that the active site of Txl-1 homologues in
lower eukaryotes and invertebrates contains a tryptophan res-
idue (WCGPC), as is also the case of most Trxs [10], while in
Txl-1 from vertebrates, this tryptophan residue is substituted
by a glycine residue (GCGPC). The presence of the bulky imid-
azole side chain of Trp31 has been proposed to regulate the
catalytic activity of Trxs [16]. Indeed, we found that the thio-
redoxin activity kinetics are considerably diﬀerent between
TXL-1 and TRX-1, making it reasonable to speculate that
the substitution of Trp31 to Gly31 might explain this diﬀer-
ence. Nonetheless, the biological signiﬁcance of this change re-
quires further analysis.
High expression of Txl-1 mRNA could be seen in tissues
which mainly use glucose as an energy source and low expres-
sion in tissues which utilize fatty acids as energy supplier. This
ﬁnding aimed us to further investigate the localization of Txl-10
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non-transfected (n.t.) HEK-293 cells or cells transfected with empty pCDNA-
PAGE and immunoblotted with anti-TXL-1 and anti-b-actin. Extracts fro
antibody corresponding to the endogenous TXL-1 (lower band) and the myc
293 stably transfected cells (TXL-1–6 and TXL-1–16) compared with HEK-
indicate means ± S.E.M. with data expressed as percentage of living cells. Com
Student–Newman–Keuls post hoc test (N = 8, P < 0.05). Statistical signiﬁcanin brain, which in normal situation relies solely on glucose.
Our results show that Txl-1 can be seen either in the nucleus
or the cytoplasm of diﬀerent cells types in the brain (Fig. 3).
In addition, a TXL-1–GFP fusion protein also displays both
nuclear and cytoplasmic localization (Supplementary Data
Fig. 2), thus conﬁrming the TXL-1 subcellular localization pat-
tern observed with immunocytochemistry. However, there is
no nuclear targeting signal in the TXL-1 sequence. In close
parallelism, TRX-1 can also translocate into the nucleus under
certain conditions [7] without such targeting signal in its se-
quence. The roles of TRX-1 in nucleus and cytoplasm seem
to be diﬀerent [7,35] and it has been shown that nuclear
TRX-1 modulates, in a redox-dependent manner, the DNA
binding activity of transcription factors [15,36], including nu-
clear receptors [6,19]. Taken together, we may speculate that
regulation of activity of transcription factors might be one role
of TXL-1 within the nucleus and that TXL-1 might be an
important factor in protecting nervous system against the ef-
fects of hypoglycemia.
TXL-1 expression is clearly modulated by glucose depriva-
tion in HEK-293 cells since TXL-1 protein levels are reduced
after 36 h in this condition (see Fig. 5B). Unlike TXL-1,
TRX-1 levels do not change after 48 h in a glucose-free med-
ium. This result indicates that TXL-1 might be speciﬁcally in-
volved in the cellular response to glucose deprivation. It is well
accepted that glucose deprivation-induced cytotoxicity is
mediated by the generation of reactive oxygen species, e.g.,
hydrogen peroxide, that promotes the activation of the c-Jun
N-terminal kinase (JNK-1) pathway through the disruption
of the interaction between TRX-1 and the apoptosis signaling36 48 72
ours)
empty vector
TXL-1-6
TXL-1-16
Txl-1
Actin
6
*
*
TX
L-1
-16
privation-induced cytotoxicity. Upper panel, cell lysates (25 lg) from
myc or pCDNA-myc/TXL-1 (clones 6 and 16) were separated by SDS–
m TXL-1–6 and TXL-1–16 clones show two bands with anti-TXL-1
-TXL-1 (upper band). Lower panel, cell viability MTT assay of HEK-
293 cells stably transfected with the empty pCDNA-myc vector. Bars
parisons among clones were performed using ANOVA followed by the
t diﬀerences are indicated with an asterisk.
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progression of the apoptotic process and cell death [29–31].
However, TXL-1 expression is not aﬀected by hydrogen perox-
ide exposure, so the eﬀect of glucose deprivation on TXL-1
expression must be mediated through a diﬀerent pathway
where hydrogen peroxide is not involved.
We have also found that overexpression of TXL-1 over a
certain threshold can protect HEK-293 cells against glucose-
deprivation cytotoxicity. Signiﬁcant diﬀerences in cell survival
appear after 48 h treatment when comparing clones with high-
est TXL-1 levels. Before 36 h, cell survival is comparable in all
clones, most probably because endogenous TXL-1 levels are
high enough to maintain the cellular integrity. However, after
36 h and onwards only the TXL-1–6 clone showing the highest
expression level is able to protect cells to some extent from glu-
cose deprivation-induced cytotoxicity. Again, hydrogen perox-
ide-induced cytotoxicity is not prevented by TXL-1
overexpression supporting our previous idea that TXL-1 must
function in a pathway where hydrogen peroxide is not in-
volved.
In summary, we propose TXL-1 to be involved in the cellu-
lar response against glucose deprivation. However, more
experiments are required to elucidate the speciﬁc mechanism
and the molecular targets of TXL-1 in this particular process.
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